KEENA HARRISON: Open Payments
NPI 1790334696 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 24 payments from 5 companies in 2025. Trend: 2023 $1,107 · 2024 $645 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $507 |
| Boston Scientific Corporation | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Alkermes, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: QULIPTA, BOTOX, WaveWriter Alpha Prime 16, VRAYLAR, COBENFY, VIVITROL, CAPLYTA.
Industry payments across CA — which companies pay providers there.
